Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celanese (CE) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Celanese (CE) over the last 17 years, with Q3 2025 value amounting to $1.4 billion.

  • Celanese's Cash & Equivalents rose 7712.18% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 7712.18%. This contributed to the annual value of $962.0 million for FY2024, which is 4670.36% down from last year.
  • Per Celanese's latest filing, its Cash & Equivalents stood at $1.4 billion for Q3 2025, which was up 7712.18% from $1.2 billion recorded in Q2 2025.
  • Over the past 5 years, Celanese's Cash & Equivalents peaked at $9.7 billion during Q3 2022, and registered a low of $536.0 million during Q4 2021.
  • Over the past 5 years, Celanese's median Cash & Equivalents value was $1.2 billion (recorded in 2025), while the average stood at $1.6 billion.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 62171.64% in 2022, then plummeted by 8596.84% in 2023.
  • Quarter analysis of 5 years shows Celanese's Cash & Equivalents stood at $536.0 million in 2021, then surged by 181.34% to $1.5 billion in 2022, then grew by 19.69% to $1.8 billion in 2023, then plummeted by 46.7% to $962.0 million in 2024, then surged by 49.69% to $1.4 billion in 2025.
  • Its Cash & Equivalents stands at $1.4 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $951.0 million for Q1 2025.